CHEK1 and cancer: As inhibition of CHK1 can trigger DNA damage and apoptosis in cancer cell lines but may also prevent expansion of primary cells, we investigated the impact of a gene-dosage reduction and graded inhibitor treatment on bone marrow derived pro-B cells, isolated by cell sorting and cultured in the presence of Interleukin-7.